Aamir Malik is Executive Vice President, Chief U.S. Commercial Officer, Pfizer Inc. Aamir is a member of Pfizer’s Executive Leadership Team (ELT). He leads the U.S. Commercial business, which consists of U.S. Primary and Specialty Care, as well as Global Value and Access, Global Medical Affairs, and Global Chief Marketing Office organizations. 

Previously Aamir served as the Executive Vice President, Chief Business Innovation Officer, responsible for the company’s strategy, business development, commercial development, portfolio management, pipeline prioritization, and formation of new business ventures.

Prior to joining Pfizer, Aamir was the Managing Partner of McKinsey & Company’s United States operations and previously led the firm’s Global Pharmaceutical and Medical Products Practice. In his 25 years at McKinsey, Aamir developed innovative growth strategies, guided mergers and acquisitions, and implemented high-impact programs to improve patients’ lives and transform performance for life science companies. He has advised many Boards, CEOs, and top management teams in the life science space.

Aamir earned a Bachelor of Science in finance from Indiana University and currently serves on the University’s Kelly School of Business Dean’s Council. He is an active advocate for bettering the lives of people with food allergies and has lived and worked globally, including in the United States, Europe, Asia, Latin America, and Africa.